REFERENCES
- Leuenberger H., Bier H.P., Sucker H.B. Pharm. Technol. 1979; 3(6)61–68
- Timko R.J., Johnson J.L., Skinner J.W., Chen S.T., Rosenberg H.A. Drug Dev. Ind. Pharm. 1986; 12(10)1375–1393
- Schildcrout S.A. J. Pharm. Pharmacol. 1984; 36: 502–505
- Rowe R.C., Parker M.D. Pharm. Technol. 1994, March: 74–82
- Parker M.D., Rowe R.C., Upjohn N.G. Pharm. Technol. Int. 1990, September: 50–64
- Johansen A., Schaefer T., Kristensen H.G. Int. J. Pharm. 1999; 183: 155–164
- Hancock B.C., York P., Rowe R.C. Int. J. Pharm. 1992; 83: 147–153
- Caleva MTR Customer User Manual. Caleva Process Solutions Limited
- Faure A., Grimsey I.M., Rowe R.C., York P., Cliff M.J. J. Pharm. Sci. 1999; 88(2)191–195
- Luukkonen P., Schaefer T., Hellen L., Juppo A.M., Yliruusi J. Int. J. Pharm. 1999; 188: 181–192
- Travers D.N., Rogerson A.G., Jones T.M. J. Pharm.Pharmacol. 1975; 27: 3P